Catalog Advanced Search
188 Results
-
Includes a Live Web Event on 02/18/2026 at 11:00 AM (PST)
Content provided by Baxter (No CE credits offered)
Webinar Description:
Date: Wednesday, February 18, 2026
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
Hospital-onset sepsis remains a significant driver of morbidity and mortality, often hinging on how quickly it is recognized and escalated. This sponsored webinar explores the critical role of rapid response teams and Code Sepsis activation in improving outcomes for in-patients with hospital-onset sepsis. Participants will examine current literature supporting early identification and timely diagnosis during rapid response events, with a focus on practical indicators that prompt action. Through a case-based discussion, learners will apply evidence-based strategies to real-world scenarios, strengthening clinical judgment, and reinforcing the life-saving impact of making the right call at the right time.
Objectives:
- Restate the impact of hospital-onset sepsis recognition and diagnosis
- Review literature to support early identification of sepsis in rapid response/Code Sepsis
- Apply the literature discussed into case-based application
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Baxter for this sponsored webinar.
Angela Craig, MS, APN, CCNS, CCRN
Senior Medical Manager, Medical Affairs
Baxter
Angela Craig, MS, APN, CCNS, CCRN, currently works as a full time Medical Science Liaison for Baxter. She focuses on the evidence and best practices for fluid management. She has maintained her PRN status at Cookeville Regional Medical Center (CRMC) where she was the Clinical Nurse Specialist of the ICU for 16 years. She has been a Clinical nurse specialist for over 25 years. She also chaired her hospital’s sepsis team and led her hospital to be the first sepsis disease specific certified hospital in the state of Tennessee. Angela is also a Sepsis Alliance Advisory Board Member. She has a passion for making outcomes for sepsis and all patients a priority. She has worked with area nursing homes/long term care facilities/Home health care and EMS to increase early identification of potential infections and how to best treat. She has spoken at the local, state and national level on the topics of sepsis and hemodynamics. She has consulted for multiple companies with various critical care products.
Angela recently published in December 2023 in AACN Journal of Advanced Critical Care “Advanced Variables to Optimize Hemodynamic Monitoring” and is a contributing author for the book Critical Care Nursing Certification Review which was published in April 2024.
She also is a contributing editor to the 8th edition of the Critical Care Nursing Certification Review CCRN Prep and Practice Exams book for the chapters: Sepsis and Multiorgan Syndrome, Toxic emergencies, and airway Obstruction Copyright 2024.
Prior to CRMC, she was faculty for Lansing Community College, Lansing Michigan in their nursing program for 5 years. She also worked per diem as a Clinical Nurse Specialist at Ingham Regional Medical Center in Lansing Michigan. Prior to this, she worked at South Suburban Hospital in Hazel Crest, Illinois as a clinical nurse specialist for 2 telemetry units and chaired the heart failure program there. When she started as a nurse over 30 years ago, she worked bedside in the intensive Care Unit at Riverside Medical Center in Kankakee Illinois.
-
Includes a Live Web Event on 02/11/2026 at 12:00 PM (PST)
This special Sepsis Survivors Week webinar, led by a sepsis survivor advocate and a clinical practice specialist, explores the multifaceted challenges faced by survivors and caregivers as they navigate lingering physical complications and the often-overlooked mental health impacts of post-sepsis syndrome.
Description:
Date: Wednesday, February 11, 2026
Time: 3:00 - 4:00 pm ET / 12:00 - 1:00 pm PT
Surviving sepsis is only the beginning of a complex recovery journey that often extends far beyond hospital discharge. This special Sepsis Survivors Week webinar, led by a sepsis survivor advocate and a clinical practice specialist, explores the multifaceted challenges faced by survivors and caregivers as they navigate lingering physical complications and the often-overlooked mental health impacts of post-sepsis syndrome. Attendees will gain insight into the interplay between physiological changes and psychological outcomes, including how these factors can contribute to misdiagnosis and delayed treatment. Practical strategies for discharge planning and ongoing support will be highlighted, equipping clinicians with tools to foster holistic, trauma-informed care that addresses both body and mind.
Learning Objectives:
At the end of the activity, the learner should be able to:
- List four physical and four mental symptoms of post-sepsis syndrome;
- Describe three ways survivors or caregivers can engage in post-sepsis discharge planning;
- Identify how sepsis-associated pathophysiology influences psychiatric misdiagnosis in survivors.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sarah Wells, MSN, RN, CEN, CNL
Clinical Practice Specialist
American Association of Critical Care Nurses
Sarah K. Wells, MSN, RN, CEN, CNL, (she/her) is a nationally recognized nurse leader, advocate, and speaker driving innovation in workforce development, clinician and patient well-being, and healthcare technology. A trusted voice in the nursing profession, Sarah is a former emergency nurse who currently works as a Clinical Practice Specialist for the American Association of Critical-Care Nurses (AACN). Sarah is committed to improving healthcare for patients and clinicians.
Rebecca Ferguson
Sepsis Survivor and Advocate
Rebecca Ferguson is a former fashion industry leader dedicated to promoting awareness of sepsis and behavioral health.
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 12/11/2025
Annual virtual symposium on topics related to healthcare-associated infections
Description:
This event was originally recorded on December 11, 2025.
Healthcare-associated infections (HAIs) remain a leading cause of complications in healthcare settings, posing serious risks to both patients and care providers. With one in 31 hospital patients affected by an HAI on any given day, the potential for these infections to progress to sepsis highlights the urgent need for consistent, system-wide infection prevention and control efforts.
Sepsis Alliance is proud to host the 2025 Sepsis Alliance Symposium: Healthcare-Associated Infections, a free, half-day virtual event that brings together a new lineup of expert speakers to explore the latest developments in HAI prevention, treatment, and surveillance. The event will provide healthcare professionals across disciplines with up-to-date, evidence-based insights and practical tools for reducing the burden of HAIs and preventing sepsis.
Attendees will gain valuable knowledge on emerging best practices, research, and innovations in infection prevention, with a focus on translating these insights into clinical action to improve patient outcomes.
Topics covered include:
- Hospital Onset Bacteremia and Fungemia
- Health Disparities and HAI
- Sepsis and Surgical Site Infections
- ...and more!
Learning Objectives:
At the end of the activity, the learner should be able to:
- Demonstrate increased knowledge in building and maintaining compliant, effective infection prevention and control programs;
- Describe evidence-based infection prevention and control best practices;
- Identify innovative tools, approaches, and documentation processes to reduce HAIs in healthcare settings.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Cindy Hou, DO, MA, MBA, CIC, CPHQ, FACOI, FACP, FIDSA, FAPIC (Moderator)
Infection Control Officer and Medical Director of Research
Jefferson Health – New Jersey
Cindy Hou, DO, MA, MBA, CIC, CPHQ, FACOI, FACP, FIDSA, FAPIC, is the Infection Control Officer and Medical Director of Research for Jefferson Health – New Jersey and an Infectious Diseases specialist. She has expertise in sepsis, antibiotic stewardship, infection control, patient safety, clinical quality, equity, and language access.
Dr. Hou is the Chief Medical Officer of Sepsis Alliance and a member of its Board of Directors. She earned her M.B.A. and M.A. from Boston University, a D.O. from the University of New England College of Osteopathic Medicine, and her B.S. from Yale University.
Dr. Hou is the principal investigator for an Office of Minority Health grant to reduce inequities in those with limited English proficiency. She is the co-editor of the book, “COVID-19 Viral Sepsis: Impact on Disparities, Disability, and Health Outcomes.”
Dr. Hou has a Certification in Infection Prevention and Control, is a Certified Professional in Healthcare Quality, and is a Certified Professional in Patient Safety. Dr. Hou is a Fellow of the American College of Osteopathic Internists, American College of Physicians, Infectious Diseases Society of America, and Association for Professionals in Infection Control and Epidemiology.
Karen Estela MPH, RN, FAPIC
Infection Preventionist
Franciscan Missionaries of Our Lady Health System
Karen D. Estela, MPH, RN, CIC, FAPIC, is a distinguished healthcare leader at the Franciscan Missionaries of Our Lady Health System, with extensive expertise in quality, clinical nursing, and health equity. Board certified in Infection Prevention and Control and a Fellow of the Association for Professionals in Infection Control and Epidemiology (APIC), Karen has made significant strides in reducing hospital-acquired infections through active surveillance, analysis, and education. She has held prominent leadership positions, including President of the APIC River Region Chapter, and serves on APIC’s Practice Guidance Committee, helping to shape standards in infection control. Karen’s work includes presenting at national conferences and publishing research, such as her study in PLoS ONE on SARS-Cov-2 B.1.1.529 infections and recent writing in Prevention Strategist about digital quality measures for hospital-onset bacteremia and fungemia. Her achievements have been recognized with honors including the 2022 Celebrate Nursing Award, the 2022 Great 100 Nurses of Louisiana Honor, and the 2025 Nightingale Award for Outstanding Community Achievement by a Nurse. Through her leadership and advocacy, Karen continues to drive improvements and promote inclusiveness in healthcare.
Paul Feuerstadt MD, FACG, AGAF, FRCPE
Associate Clinical Professor of Medicine, Attending Gastroenterologist
Yale University School of Medicine; Gastroenterology Center of Connecticut/PACT-Gastroenterology Center
Paul Feuerstadt MD, FACG, AGAF, FRCPE, is a gastroenterologist practicing at the PACT-Gastroenterology Center and is an Associate Clinical Professor of Medicine at the Yale School of Medicine.
Dr. Feuerstadt’s focus includes the microbiota, C. difficile infection, eosinophilic disorders, intestinal ischemia, and acute and chronic changes in bowel habits. He has been a principal investigator on numerous clinical trials in these spaces. Within his practice, he is very active in teaching and volunteer work, locally and nationally for disease and discipline-specific initiatives.
Dr. Feuerstadt has authored and co-authored many manuscripts and textbook chapters. Another passion of Dr. Feuerstadt’s is teaching, frequently giving lectures locally, regionally, nationally, and internationally. He works extensively with the gastroenterology fellows in the Division of Digestive Disease at Yale-New Haven Hospital.
His clinical practice at the PACT Gastroenterology Center is his ultimate passion, filling the majority of his work time.
Darlene K. Jubah, DNP, MPH, RN, CIC, NEA-BC
Regional Manager Infection Prevention
Inspira Medical Centers Mullica Hill, Mannington &Woodbury
Darlene K. Jubah, DNP, MPH, RN, CIC, NEA-BC, is a nurse with over 20 years of healthcare experience. As of 2022, she works as the Regional Manager, Infection Prevention at Inspira Health Network in New Jersey. Previously, she worked as an Infection Preventionist at other acute care facilities in the Philadelphia and New Jersey areas. She also currently serves as the president-elect for the Association for Professionals in Infection Control and Epidemiology-APIC, Chapter 011- New Jersey.
Dr. Jubah is the owner and consultant at Keita Public Health Consulting. She offers expert advisory on healthcare, community and acute care prevention, and control practices as well as health promotion and disease prevention to community and organization leaders and executives.
Through her passion for education and coaching, Dr. Jubah serves as a part-time Clinical Adjunct Instructor. She is very passionate about empowering others through lived experiences and a shared vision of nursing empowerment and health equity.
Dr. Jubah is double board certified in Infection Control (CIC) and Nurse Executive Advanced (NEA-BC) and is a Lean Six Sigma Yellow Belt. She holds a doctorate in Nursing Practice and a Master’s in Public Health.
Fizza Manzoor, MD
Research Fellow, Department of Population Medicine
Harvard Pilgrim Health Care Institute
Fizza Manzoor, MD, is a research fellow in the Department of Population Medicine at Harvard Pilgrim Health Care Institute. Her work focuses on advancing surveillance methods for healthcare-associated infections with a focus on hospital-onset sepsis. She received her medical degree and completed internal medicine residency at the University of Toronto, followed by infectious diseases fellowship training at Massachusetts General Hospital and Brigham and Women’s Hospital.
Caitlin McGrath, MD, MS
Assistant Professor of Pediatrics, Infectious Diseases
Washington University School of Medicine
Caitlin McGrath, MD, MS, is an Assistant Professor of Pediatrics in the Division of Pediatric Infectious Diseases at the Washington University School of Medicine in St. Louis, Missouri. Originally from the Midwest, she completed medical school at UCLA, followed by a pediatrics residency and pediatric infectious diseases fellowship at the University of Washington and Seattle Children’s Hospital.
Dr. McGrath serves as Associate Medical Director for Infection Prevention for St. Louis Children’s Hospital. Her research interests include CLABSI prevention, and the intersection of HAIs with health equity. She cares for patients on the inpatient infectious diseases consult service and in general infectious diseases outpatient clinic. She enjoys partnering with patients, families, and care teams throughout the hospital to work collaboratively to prevent and treat infections. Outside of work, she enjoys spending time with her family, including her two young daughters, and exploring local parks and kid-friendly destinations.
Chanu Rhee, MD, MPH, FIDSA
Associate Professor of Population Medicine / Infectious Disease and Critical Care Physician
Harvard Medical School / Harvard Pilgrim Health
Chanu Rhee, MD, MPH, is an Associate Professor of Population Medicine at Harvard Medical School and an infectious disease and critical care physician at Brigham and Women's Hospital. He is internationally recognized for his contributions and expertise in the epidemiology, surveillance, diagnosis, prevention, and management of sepsis and infections in critically ill patients. He conducts clinical and epidemiologic research with a particular focus on harnessing electronic health record data to generate insights that advance clinical practice, quality improvement, public health strategy, and healthcare policy. Dr. Rhee has been a leader in sepsis quality improvement efforts within the Mass General Brigham system and has participated in many national committees focused on improving sepsis care and outcomes, including in his current role as Chair of the Infectious Diseases Society of America’s Sepsis Advisory Panel.
Dr. Rhee is an associate editor for Clinical Infectious Diseases, a member of the editorial boards for Critical Care Medicine and Critical Care Explorations, and a Fellow of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, and the American College of Critical Care Medicine.
Alex Sadorf Colvin
Director, Marketing and Communications
Sepsis Alliance
Alex graduated from the University of California, Davis with a B.A. in Communication. After spending her senior year as Fundraising Chair for the women’s rugby team, Alex returned home to San Diego to plan events for military housing and then work as an Independent Contractor in marketing and event planning.
Alex started with Sepsis Alliance as the Events Coordinator in 2017. She then supported events, operations, and stewardship before moving to Communications and Marketing. She has a passion for sharing accurate, engaging information to help raise sepsis awareness.
Now located in the Bay Area, Alex keeps active by chasing her son and dog around.
Katie Taylor, MD
Medical Director of Infection Prevention
Our Lady of the Lake Health
Katie V. Taylor, MD, is the Medical Director of Infection Prevention at Our Lady of the Lake Health and is an Assistant Professor of Clinical Medicine at Louisiana State University Health Sciences Center (LSUHSC). She received her BS in Biochemistry from Louisiana State University and her MD from LSU School of Medicine in New Orleans. Dr. Taylor completed her Internal Medicine residency at LSUHSC in Baton Rouge followed by Infectious Diseases fellowship at University of Florida. During medical school and residency, she was awarded for excellence in teaching by her peers. Her clinical duties include supervising LSU Infectious Diseases service at Our Lady of the Lake Health. She is the principal investigator for the research article published in PLos ONEon the clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infection. She has presented oral abstract and posters on reducing hospital-acquired infections and infectious prevention.
Glenn Werneburg MD, PhD
Physician-scientist; Urology/Infection
Glenn Werneburg, MD, PhD, is a physician-scientist and urologist in neuro-urology and pelvic reconstruction at the University of Michigan. His research focuses on urologic infection and bridges basic science, translational medicine, and emerging technologies. Dr. Werneburg serves in leadership roles across international societies, including the International Neurourology Society and the International Consultation on Incontinence–Research Society, where he has led global sessions on infection and lower urinary tract dysfunction. He has published over 60 manuscripts, is the recipient of the Diokno-Lapides Award, and has received research funding from the NIH, industry, and urologic societies. In addition to his academic work, he consults with medical technology companies on device innovation, clinical trial design, and regulatory strategy.
Time (ET) Session Title Presenter 12:00-12:10 Welcome and Opening Remarks Cindy Hou, DO, MA, MBA, FACOI, FACP, FIDSA Infection Control Officer and Medical Director of Research Jefferson Health – New Jersey 12:10-12:40 CE Session 1: Enhancing HOBSI Prevention: Data-Driven Strategies and Continuous Improvement Karen Estela MPH, RN, FAPIC
Infection Preventionist Franciscan Missionaries of Our Lady Health System
Katie Taylor, MD
Medical Director of Infection Prevention
Our Lady of the Lake Health12:45-1:15 CE Session 2: From Hospital-Acquired C. difficile to Microbiome Restoration: Evolving Therapeutic Strategies Paul Feuerstadt MD, FACG, AGAF, FRCPE
Associate Clinical Professor of Medicine, Yale University School of Medicine
Attending Gastroenterologist, Gastroenterology Center of Connecticut/PACT-Gastroenterology Center1:20-1:40 Break 1:40-2:10 CE Session 3: Advancing Surveillance of Healthcare-Associated Infections: Targeting Hospital-Onset Sepsis Chanu Rhee, MD, MPH
Associate Professor of Population Medicine, Harvard Medical School
Infectious Disease and Critical Care Physician, Brigham and Women's Hospital
Fizza Manzoor, MD
Research Fellow, Department of Population Medicine
Harvard Pilgrim Health Care Institute2:10-2:40
CE Session 4: Incorporating Equity into HAI PreventionCaitlin McGrath, MD, MS
Assistant Professor of Pediatrics, Infectious Diseases
Washington University School of Medicine2:40-3:00 Break 3:00 - 3:10 Antimicrobial Resistance Training Among Registered Nurses Alex Sadorf Colvin
Senior Director, Marketing and Communications
Sepsis Alliance3:10-3:40 CE Session 5: Sepsis and Surgical Infections: Prevention and Management for Better Outcomes Darlene Jubah, DNP, MPH, RN, CIC, NEA-BC
Regional Manager Infection Prevention
Inspira Medical Centers Mullica Hill, Mannington & Woodbury3:40-4:10 CE Session 6: Urologic Infection: Prevention and Treatment Glenn Werneburg, MD, PhD
Physician-Scientist, Urology/Infection
University of Michigan4:10-4:15 Closing Remarks Cindy Hou, DO, MA, MBA, FACOI, FACP, FIDSA Infection Control Officer and Medical Director of Research Jefferson Health – New Jersey Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 3.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 3.0 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 12/09/2025
Content provided by Abbott (No CE credits offered)
Webinar Description:
This webinar was originally recorded on December 9, 2025.
This sponsored webinar will explore the established role of lactate as a critical indicator of physiological stress and disease severity, with particular focus on its importance in the management of sepsis. In the hospital setting, serial lactate measurement through point-of-care or laboratory testing provides clinicians with real-time data that guide timely intervention and improve outcomes, yet there remains a significant blind spot once patients transition to the home environment. The inability to measure lactate outside the hospital, due to the rapid degradation of blood samples, leaves newly discharged patients and those with chronic conditions vulnerable to unrecognized deterioration and avoidable readmission. The session will highlight the limitations of current practice, the clinical consequences of delayed recognition, and the potential impact of new approaches to lactate monitoring, drawing on current work examining sepsis readmission risk and opportunities to strengthen continuity of care.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Abbott for this sponsored webinar.
Gabriel Wardi, MD, MPH, FACEP
Associate Professor & Chief, Division of Emergency Critical Care, Department of Emergency Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine
University of California, San Diego
Gabriel Wardi, MD, MPH, FACEP, is a board-certified emergency physician cross-trained in internal medicine and critical care at the University of California, San Diego (UC San Diego), where he is also an associate professor in the Department of Emergency Medicine and Division of Pulmonary, Critical Care, and Sleep Medicine. He is the founding Chief of the Division of Emergency Critical Care within the Department of Emergency Medicine.
The major focus of his career has been on improving the diagnosis and outcomes of sepsis patients. He is the Medical Director of Hospital Sepsis at UC San Diego, a position he has had since 2018. In this role, he has overseen a 40% drop in sepsis mortality. He has been funded by the National Institutes of Health and the Gordon and Betty Moore Foundation to investigate novel approaches to improve care of patients with sepsis through big data and machine-learning approaches. Dr. Wardi has been selected by his peers as a "Top Doctor" in San Diego multiple times.
Dr. Wardi has over 160 peer-reviewed manuscripts, abstracts, and book chapters published focusing on care of patients with sepsis and novel approaches using AI in medicine to improve patient-centered outcomes.
Add to your calendar for easy access:
-
Recorded On: 12/04/2025
Content provided by Diasorin (No CE credits offered)
Webinar Description:
This webinar was originally recorded on December 4, 2025.
Join this sponsored webinar which introduces the LIAISON PLEX® Bloodstream Infection (BSI) portfolio: Smart, clinically relevant diagnostic solutions designed to close critical gaps in bloodstream infection management. Moving beyond conventional panels, this session highlights how LIAISON PLEX BSI’s split-panel design, expanded resistance gene coverage, and unique technology support timely therapeutic decisions, and antimicrobial stewardship. Discover how this platform enhances diagnostic precision, streamlines workflow integration, and drives better patient outcomes.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Diasorin for this sponsored webinar.
Sherry Dunbar, PhD, MBA
Senior Director of Scientific Affairs Programs
Diasorin
Sherry Dunbar, PhD, MBA, holds a B.S. in Microbiology and Immunology, and an MBA from the University of Maryland. She earned her Ph.D. in Medical Microbiology and Immunology from the University of South Alabama, followed by a post-doctoral fellowship in Clinical and Public Health Microbiology at Baylor College of Medicine. She previously served as the Clinical Laboratory Director at Virus Reference Laboratory in Houston, Texas.
In 1999, Dr. Dunbar joined Luminex as a Senior Scientist, where she led the Biology Research and Development group as Senior Director for eight years. Her team was instrumental in developing assay protocols, techniques, and best practices for xMAP Technology. She then served as Senior Director of Global Scientific Affairs for Luminex for eleven years.
Dr. Dunbar is currently the Senior Director of Scientific Affairs Programs at Diasorin, where she supports scientific activities related to the company’s diagnostic and research products. She has authored over fifty peer-reviewed publications and has presented numerous abstracts and seminars at scientific conferences.
-
By connecting science with culture and care, this webinar underscores how equitable approaches can transform outreach into meaningful, lasting confidence in vaccination.
Description:
Date: Tuesday, November 18, 2025
Time: 1:00 - 2:00 pm ET / 10:00 - 11:00 am PT
Building trust in vaccines requires more than sharing facts. It calls for understanding the human experiences that shape decision-making. This webinar explores the psychological, cultural, and linguistic influences that contribute to hesitancy, highlighting the role of empathy and respect in effective dialogue. Practical strategies grounded in patient-centered communication will be examined alongside collaborative models that bring healthcare teams and community partners together. By connecting science with culture and care, this webinar underscores how equitable approaches can transform outreach into meaningful, lasting confidence in vaccination.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Identify key psychological, cultural, linguistic and systemic factors that contribute to vaccine hesitancy;
- Apply patient-centered communication strategies to address misinformation and to build vaccine trust;
- Evaluate collaborative care models and cross-functional strategies that promote vaccine equity and strengthen community-level outreach efforts.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
This activity is supported by an independent medical education grant from Sanofi US (monetary support).
Sepsis Alliance gratefully acknowledges the monetary support provided for this webinar by the Sepsis Alliance Institute sponsors.
Cindy Hou, DO, MA, MBA, CIC, CPHQ, FACOI, FACP, FIDSA, FAPIC
Infection Control Officer and Medical Director of Research
Jefferson Health – New Jersey
Cindy Hou, DO, MA, MBA, CIC, CPHQ, FACOI, FACP, FIDSA, FAPIC, is the Infection Control Officer and Medical Director of Research for Jefferson Health – New Jersey and an Infectious Diseases specialist. She has expertise in sepsis, antibiotic stewardship, infection control, patient safety, clinical quality, equity, and language access.
Dr. Hou is the Chief Medical Officer of Sepsis Alliance and a member of its Board of Directors. She earned her M.B.A. and M.A. from Boston University, a D.O. from the University of New England College of Osteopathic Medicine, and her B.S. from Yale University.
Dr. Hou is the principal investigator for an Office of Minority Health grant to reduce inequities in those with limited English proficiency. She is the co-editor of the book, “COVID-19 Viral Sepsis: Impact on Disparities, Disability, and Health Outcomes.”
Dr. Hou has a Certification in Infection Prevention and Control, is a Certified Professional in Healthcare Quality, and is a Certified Professional in Patient Safety. Dr. Hou is a Fellow of the American College of Osteopathic Internists, American College of Physicians, Infectious Diseases Society of America, and Association for Professionals in Infection Control and Epidemiology.
Accreditation Statements
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Financial Relationship Disclosures:
Cindy Hou disclosed the following relevant financial relationships:
- Advisory board member for Abbott
- Panelist for Sanofi
All relevant financial relationships have been mitigated.
All other individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Register for this if you plan to claim CE credits for 3+ podcast episodes.
Description:
This package includes the CE evaluations and CE credits for each individual podcast episode. You can register for the individual episode evaluations if you plan to complete fewer than three.
This season of The Sepsis Spectrum explores one of the most critical complications of sepsis: multi-organ dysfunction syndrome (MODS). Designed specifically for healthcare professionals, this six-episode series will strengthen your clinical insight and decision-making across the continuum of sepsis care. Each episode focuses on the effects of sepsis on a specific organ system, shedding light on how dysfunction in each area develops, how to recognize it early, and how to intervene effectively.
Through real-world case examples and expert interviews, you’ll gain practical strategies to support early detection, multidisciplinary care, and post-acute recovery. Whether you work in emergency care, critical care, or transitional care settings, this series will help you better understand the systemic nature of sepsis, how organ failure evolves, and how to act swiftly to improve outcomes.
Learning Objectives:
At the end of the series, the learner should be able to:
- Describe the pathophysiology of multi-organ dysfunction syndrome (MODS) in the context of sepsis.
- Identify early signs of organ-specific dysfunction in patients with suspected or confirmed sepsis.
- Apply clinical strategies to prevent or mitigate organ failure during sepsis management.
- Analyze the implications of single vs. multi-organ failure on patient outcomes and care pathways.
- Recognize the role of interdisciplinary teams in diagnosing, monitoring, and managing organ dysfunction.
- Evaluate post-ICU and post-sepsis recovery considerations related to organ damage and long-term function.
- Implement evidence-based interventions tailored to each organ system affected by sepsis.
Target audience:
All healthcare professionals and healthcare students including nurses, physicians, advanced practice providers, pharmacists, infectious disease and prevention specialists, scientists, and researchers, sepsis coordinators, sepsis data & quality professionals, healthcare executives and leadership, nursing and medical school deans & faculty, professional healthcare organizations, healthcare advocates, government, and industry.
CE Information:
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 4.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 3.0 contact hours.
Financial Relationship Disclosures:
All individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer:
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 11/11/2025
Content provided by Abionic (No CE credits offered).
Webinar Description:
When a patient with suspected sepsis arrives in the emergency department, every minute matters. This sponsored webinar brings together Sepsis Coordinators and frontline nurses for a candid discussion on how early detection, triage workflows, and diagnostic tools can mean the difference between recovery and rapid decline.
Moderated by Heather Orgeron, DNP, MSN, RN, Performance Improvement Supervisor, Stroke Coordinator, and Sepsis Coordinator at Ochsner Health, the panel builds on insights from the June 2025 national focus group on sepsis workflow. Speakers will explore real-world challenges, from early warning system gaps and EHR alert fatigue to the urgent need for faster, more actionable point-of-care diagnostics.
Attendees will learn practical strategies to:
- Strengthen sepsis screening and escalation protocols;
- Reduce workflow delays that cost critical time;
- Bridge the gap between clinical practice and diagnostic innovation.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Abionic for this sponsored webinar.
Heather Orgeron, DNP, MSN, RN (Moderator)
Performance Improvement Supervisor, Stroke Coordinator, Sepsis Coordinator
Ochsner Health
Heather Orgeron, DNP, MSN, RN, is the Performance Improvement Supervisor, Stroke Coordinator, and Sepsis Coordinator at Ochsner Health in Slidell, Louisiana. A dynamic nursing leader with over a decade of experience, Heather specializes in driving clinical excellence through data-driven quality improvement initiatives. Her leadership in sepsis care has led to significant improvements in emergency department outcomes at two local hospitals, including increased order set utilization and dramatic reductions in door-to-antibiotic times, enhancing timely treatment and protocol adherence. Heather is passionate about empowering nurses and fostering interdisciplinary collaboration to elevate patient care. She also serves as adjunct faculty at Southeastern Louisiana University School of Nursing, mentoring first-year students in clinical practice. A recipient of multiple nursing excellence awards, Heather continues to champion innovative strategies that improve care delivery and patient outcomes.
William Van Why BSN, RN, TCCC, EMT-P
Sepsis Coordinator
Baptist HealthCare
William Van Why, BSN, RN, TCCC, EMT-P, is a Sepsis Coordinator at Baptist HealthCare, where he focuses on acute sepsis cases in the Emergency Department, Acute Care, and Intensive Care units. William is also the chair of the Sepsis Task Force that includes a team of practitioners, department managers, quality managers, and pharmacists. This program saw 30% sepsis bundle compliance just two years ago with an observed over expected (O/E) mortality ratio of 1.4. Their current state is a sepsis bundle compliance rate of 66% with an O/E ratio of 0.84. The largest focus of this program is placed on sepsis awareness and mortality reduction through bundle compliance. It's no surprise that mortalities increase when sepsis bundle compliance decreases. Demonstrating this correlation with their practitioner partners has dramatically decreased their observed mortalities and led to lower length of stay times for patients. -
By connecting science with culture and care, this webinar underscores how equitable approaches can transform outreach into meaningful, lasting confidence in vaccination.
Description:
Date: Thursday, November 6, 2025
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
Sepsis remains a critical public health concern, often stemming from common bacterial infections that can often be prevented. This informative webinar explores the essential role vaccines play in reducing the prevalence and burden of bacterial sepsis. By examining the most common bacterial causes and the science behind vaccine development, this presentation highlights how immunization strategies disrupt the pathways that lead to severe infection. Attendees will also gain insight into the rigorous processes that ensure vaccine safety and effectiveness in the fight against life-threatening illness, as well as key factors influencing vaccine confidence and hesitancy.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe why vaccines are important for preventing sepsis
- Identify the major bacterial pathogens causing sepsis
- Review principles of vaccinology, bacterial vaccine development, and safety monitoring
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
This activity is supported by an independent medical education grant from Sanofi US (monetary support).
Sepsis Alliance gratefully acknowledges the monetary support provided for this webinar by the Sepsis Alliance Institute sponsors.
Robert Donald, PhD
Retired Research Microbiologist
Robert Donald, PhD, is a research microbiologist with broad experience in bacterial, viral, and eukaryotic parasitic systems. While a senior research fellow at Merck, he contributed to drug discovery programs to identify new antibiotics to prevent S. aureus, antifungal, and parasitic infections. More recently, while a senior director at Pfizer, he led a preclinical vaccine development program targeting Klebsiella and E. coli invasive infections. Prior to this, he was also the scientific lead for preclinical programs advancing C. difficile, Enterococcus, and Group B Streptococcus vaccines, while managing supporting molecular biology and assay development teams.
Robert became motivated to assist with Sepsis Alliance’s mission due to his “firsthand” experience with the invasive bacterial pathogens that cause sepsis, and familiarity with emerging therapeutic or vaccine-based strategies currently under development in academia and biotech/pharma sectors. Now retired from commercial R&D, he seeks to contribute scientifically through advising and educating. In addition to serving on the Sepsis Alliance Advisory Board, he is consultant to Carb-X, whose mission is to fund research to develop new therapies and vaccines to address antimicrobial drug resistance.
Robert is a graduate of the University of California Santa Cruz, and did post-doctoral research at the University of California Berkeley and the University of Pennsylvania.
Accreditation Statements
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Financial Relationship Disclosures:
Robert Donald disclosed the following relevant financial relationship:
- Former employee, Pfizer
All relevant financial relationships have been mitigated.
All other individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Content provided by Abbott (No CE credits offered)
Webinar Description:
This sponsored webinar will explore the established role of lactate as a critical indicator of physiological stress and disease severity, with particular focus on its importance in the management of sepsis. In the hospital setting, serial lactate measurement through point-of-care or laboratory testing provides clinicians with real-time data that guide timely intervention and improve outcomes, yet there remains a significant blind spot once patients transition to the home environment. The inability to measure lactate outside the hospital, due to the rapid degradation of blood samples, leaves newly discharged patients and those with chronic conditions vulnerable to unrecognized deterioration and avoidable readmission. The session will highlight the limitations of current practice, the clinical consequences of delayed recognition, and the potential impact of new approaches to lactate monitoring, drawing on current work examining sepsis readmission risk and opportunities to strengthen continuity of care.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Abbott for this sponsored webinar.
Gabriel Wardi, MD, MPH, FACEP
Associate Professor & Chief, Division of Emergency Critical Care, Department of Emergency Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine
University of California, San Diego
Gabriel Wardi, MD, MPH, FACEP, is a board-certified emergency physician cross-trained in internal medicine and critical care at the University of California, San Diego (UC San Diego), where he is also an associate professor in the Department of Emergency Medicine and Division of Pulmonary, Critical Care, and Sleep Medicine. He is the founding Chief of the Division of Emergency Critical Care within the Department of Emergency Medicine.
The major focus of his career has been on improving the diagnosis and outcomes of sepsis patients. He is the Medical Director of Hospital Sepsis at UC San Diego, a position he has had since 2018. In this role, he has overseen a 40% drop in sepsis mortality. He has been funded by the National Institutes of Health and the Gordon and Betty Moore Foundation to investigate novel approaches to improve care of patients with sepsis through big data and machine-learning approaches. Dr. Wardi has been selected by his peers as a "Top Doctor" in San Diego multiple times.
Dr. Wardi has over 160 peer-reviewed manuscripts, abstracts, and book chapters published focusing on care of patients with sepsis and novel approaches using AI in medicine to improve patient-centered outcomes.
Add to your calendar for easy access: